China’s cancer breakthrough on CAR-T cell therapy shows progress
In June, Chinese regulators approved the world’s first CAR-T cell therapy for solid tumour cancers, developed by a drug company based in Shanghai. One month later, at a hospital in the city, a New Zealander with advanced cancer of the stomach and small intestine became the first international patient to receive the breakthrough treatment. Chimeric antigen receptor T-cell therapy, to give it its…
We haven't written up this one. South China Morning Post has the full story — the link below goes straight to it.
